A long-term glycyrrhizin injection therapy reduces hepatocellular carcinogenesis rate in patients with interferon-resistant active chronic hepatitis C: a cohort study of 1249 patients.

Digestive Diseases and Sciences
Kenji IkedaH Kumada

Abstract

To elucidate the influence of a glycyrrhizin therapy on hepatocarcinogenesis rate in interferon (IFN)-resistant hepatitis C, we retrospectively analyzed 1249 patients with chronic hepatitis with or without cirrhosis. Among 346 patients with high alanine transaminase value (twice or more of upper limit of normal), 244 patients received intravenous glycyrrhizin injection and 102 patients did not, after judgment of IFN resistance. Crude carcinogenesis rates in the treated and untreated group were 13.3%, 26.0% at the 5th year, and 21.5% and 35.5% at the 10th year, respectively (P = .0210). Proportional hazard analysis using time-dependent covariates disclosed that glycyrrhizin treatment significantly decreased the hepatocarcinogenesis rate (hazard ratio 0.49, 95% confidence interval 0.27-0.86, P = .014) after adjusting the background features with significant covariates. Glycyrrhizin injection therapy significantly decreased the incidence of hepatocellular carcinoma in patients with IFN-resistant active chronic hepatitis C, whose average aminotransferase value was twice or more of upper limit of normal after interferon.

References

Sep 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·F HasanG Kuo
Jul 1, 1993·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K IkedaM Kawanishi
Feb 1, 1994·Journal of Medical Virology·W B BarhamK C Hyams
Jun 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·V J DesmetP J Scheuer
Jan 1, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M C YuS Govindarajan
May 15, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A KasaharaK Okita

❮ Previous
Next ❯

Citations

Sep 20, 2012·Evidence-based Complementary and Alternative Medicine : ECAM·Anna Del PreteCarmelina Loguercio
Nov 5, 2010·Journal of Translational Medicine·Giuseppe CastelloStefania Scala
May 24, 2012·Virology Journal·Michele E HardyNicholas R Faunce
Aug 22, 2009·Chinese Medicine·Yibin FengYao Tong
Mar 26, 2008·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·Katsuya Shiraki, Yoshiyuki Takei
Jun 3, 2011·World Journal of Gastroenterology : WJG·Tomohiro KudoMasatomo Mori
Apr 4, 2014·World Journal of Gastroenterology : WJG·Romilda CardinFabio Farinati
Nov 16, 2010·Antiviral Research·Jin-Ching LeeYang-Chang Wu
Sep 11, 2007·European Journal of Pharmacology·Tsuyoshi YoshidaHideo Inoue
Aug 19, 2007·Liver International : Official Journal of the International Association for the Study of the Liver·John M LukSheung-Tat Fan
Sep 20, 2007·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Kenji Ikeda
Jun 13, 2008·Biopharmaceutics & Drug Disposition·Kenjiro KogaKanji Takada
Jan 22, 2013·Hepatology Research : the Official Journal of the Japan Society of Hepatology·
Mar 4, 2014·Molecular Nutrition & Food Research·Zhi-hong WangMei-chin Yin
Apr 17, 2010·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Izumi NamikiMasatoshi Kudo
Aug 12, 2006·Journal of Hepatology·Hellan Kang, Anna S F Lok
May 30, 2013·Journal of Hepatology·He-Xin YanQi-Long Ying
Apr 10, 2013·European Journal of Medicinal Chemistry·Aihua ZhangXijun Wang
Sep 22, 2007·Phytotherapy Research : PTR·Cristina FioreJens Bielenberg
Sep 10, 2020·Phytotherapy Research : PTR·Julian ChrzanowskiWojciech Graboń
Sep 23, 2011·Pharmaceutical Biology·Girija KuttanRamadasan Kuttan
Jul 3, 2021·Biomolecules·Luisa DiomedeMario Salmona
Jul 14, 2021·European Journal of Medicinal Chemistry·Shuli ManWenyuan Gao
Aug 6, 2021·Oxidative Medicine and Cellular Longevity·Javad Sharifi-RadHafiz Ansar Rasul Suleria
Jan 1, 2014·Journal of Agricultural and Food Chemistry·Tzu-Chien KaoGow-Chin Yen
Aug 12, 2021·Journal of Clinical Biochemistry and Nutrition·Keiichi HiramotoShosuke Kawanishi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.